Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2022 | Migraine | Research article

Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup

Authors: Leyi Zhang, Chenglong Lu, Li Kang, Yingji Li, Wenjing Tang, Dengfa Zhao, Shengyuan Yu, Ruozhuo Liu

Published in: The Journal of Headache and Pain | Issue 1/2022

Abstract

Background

Astrocytic activation might play a significant role in the central sensitization of chronic migraine (CM). However, the temporal characteristics of the astrocytic activation in the trigeminal nucleus caudalis (TNC) and the molecular mechanism under the process remain not fully understood. Therefore, this study aims to investigate the duration and levels change of astrocytic activation and to explore the correlation between astrocytic activation and the levels change of cytokines release.

Methods

We used a mice model induced by recurrent dural infusion of inflammatory soup (IS). The variation with time of IS-induced mechanical thresholds in the periorbital and hind paw plantar regions were evaluated using the von Frey filaments test. We detected the expression profile of glial fibrillary acidic protein (GFAP) in the TNC through immunofluorescence staining and western blot assay. We also investigated the variation with time of the transcriptional levels of GFAP and ionized calcium binding adapter molecule 1 (Iba1) through RNAscope in situ hybridization analysis. Then, we detected the variation with time of cytokines levels in the TNC tissue extraction and serum, including c-c motif chemokine ligand 2 (CCL2), c-c motif chemokine ligand 5 (CCL5), c-c motif chemokine ligand 7 (CCL7), c-c motif chemokine ligand 12 (CCL12), c-x-c motif chemokine ligand 1 (CXCL1), c-x-c motif chemokine ligand 13 (CXCL13), interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), macrophage colony-stimulating factor (M-CSF), interleukin 1beta (IL-1β), interleukin 6 (IL-6), interleukin 10 (IL-10), interleukin 17A (IL-17A).

Results

Recurrent IS infusion resulted in cutaneous allodynia in both the periorbital region and hind paw plantar, ranging from 5 d (after the second IS infusion) to 47 d (28 d after the last infusion) and 5 d to 26 d (7 d after the last infusion), respectively. The protein levels of GFAP and messenger ribonucleic acid (mRNA) levels of GFAP and Iba1 significantly increased and sustained from 20 d to 47 d (1 d to 28 d after the last infusion), which was associated with the temporal characteristics of astrocytic activation in the TNC. The CCL7 levels in the TNC decreased from 20 d to 47 d. But the CCL7 levels in serum only decreased on 20 d (1 d after the last infusion). The CCL12 levels in the TNC decreased on 22 d (3 d after the last infusion) and 33 d (14 d after the last infusion). In serum, the CCL12 levels only decreased on 22 d. The IL-10 levels in the TNC increased on 20 d.

Conclusions

Our results indicate that the astrocytic activation generated and sustained in the IS-induced mice model from 1 d to 28 d after the last infusion and may contribute to the pathology through modulating CCL7, CCL12, and IL-10 release.

Vos T, Abajobir AA, Abbafati C et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 390(10100):1211–1259. https://doi.org/10.1016/S0140-6736(17)32154-2CrossRef

Su M, Yu S (2018) Chronic migraine: a process of dysmodulation and sensitization. Mol Pain 14:174480691876769. https://doi.org/10.1177/1744806918767697CrossRef

Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15(8):483–490. https://doi.org/10.1038/s41582-019-0216-yCrossRefPubMed

Andreou AP, Edvinsson L (2019) Mechanisms of migraine as a chronic evolutive condition. J Headache Pain 20(1):117. https://doi.org/10.1186/s10194-019-1066-0CrossRefPubMedPubMedCentral

Edelmayer RM, Vanderah TW, Majuta L, Zhang ET, Fioravanti B, de Felice M, Chichorro JG, Ossipov MH, King T, Lai J, Kori SH, Nelsen AC, Cannon KE, Heinricher MM, Porreca F (2009) Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol 65(2):184–193. https://doi.org/10.1002/ana.21537CrossRefPubMedPubMedCentral

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622. https://doi.org/10.1152/physrev.00034.2015CrossRefPubMedPubMedCentral

Louter MA, Bosker JE, Van Oosterhout WPJ et al (2013) Cutaneous allodynia as a predictor of migraine chronification. Brain 136(11):3489–3496. https://doi.org/10.1093/brain/awt251CrossRefPubMed

Lukács M, Warfvinge K, Tajti J, Fülöp F, Toldi J, Vécsei L, Edvinsson L (2017) Topical dura mater application of CFA induces enhanced expression of c-fos and glutamate in rat trigeminal nucleus caudalis: attenuated by KYNA derivate (SZR72). J headache pain 18. 18(1):39. https://doi.org/10.1186/s10194-017-0746-x

Romero-Reyes M, Pardi V, Akerman S (2015) A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: role of CGRP in orofacial pain. Exp Neurol 271:95–103. https://doi.org/10.1016/j.expneurol.2015.05.005CrossRefPubMed

10.

Perini F, D’Andrea G, Galloni E et al (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931. https://doi.org/10.1111/j.1526-4610.2005.05135.xCrossRefPubMed

11.

Kang L, Tang W, Zhang Y, Zhang M, Liu J, Li Y, Kong S, Zhao D, Yu S (2021) The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice. Cephalalgia.:033310242110500. https://doi.org/10.1177/03331024211050036

12.

Jing F, Zou Q, Wang Y, Cai Z, Tang Y (2021) Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation. J Headache Pain 22(1):1–18. https://doi.org/10.1186/s10194-021-01302-xCrossRef

13.

Oshinsky ML, Gomonchareonsiri S (2007) Episodic dural stimulation in awake rats: a model for recurrent headache. Headache 47(7):1026–1036. https://doi.org/10.1111/j.1526-4610.2007.00871.xCrossRefPubMedPubMedCentral

14.

Su M, Ran Y, Han X, Liu Y, Zhang X, Tan Q, Li R, Yu S (2016) Rizatriptan overuse promotes hyperalgesia induced by dural inflammatory stimulation in rats by modulation of the serotonin system. Eur J Neurosci 44(4):2129–2138. https://doi.org/10.1111/ejn.13296CrossRefPubMed

15.

Trevisan dos Santos G, Jacobs B, Asiedu M et al (2018) Non-invasive dural stimulation in mice: A novel preclinical model of migraine. Cephalalgia 39(1):123–134. https://doi.org/10.1177/0333102418779557CrossRefPubMed

16.

Fried NT, Maxwell CR, Elliott MB, Oshinsky ML (2018) Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia. Cephalalgia 38(4):674–689. https://doi.org/10.1177/0333102417703764.Region-specificCrossRefPubMed

17.

Su M, Ran Y, He Z, Zhang M, Hu G, Tang W, Zhao D, Yu S (2018) Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine. Mol Pain 14:1–25. https://doi.org/10.1177/1744806918754612CrossRef

18.

Zhou X, Liang J, Wang J, Fei Z, Qin G, Zhang D, Zhou J, Chen L (2019) Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine. J Neurochem 155(4):1–20. https://doi.org/10.1111/jnc.14944CrossRef

19.

He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J (2019) Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation 16(1):1–17. https://doi.org/10.1186/s12974-019-1459-7CrossRefPubMedPubMedCentral

20.

Wieseler J, Ellis A, McFadden A, Stone K, Brown K, Cady S, Bastos LF, Sprunger D, Rezvani N, Johnson K, Rice KC, Maier SF, Watkins LR (2017) Supradural inflammatory soup in awake and freely moving rats induces facial allodynia that is blocked by putative immune modulators. Brain Res:1664–1694. https://doi.org/10.1016/j.brainres.2017.03.011

21.

Kwok YH, Swift JE, Gazerani P, Rolan P (2016) A double-blind, randomized, placebo-controlled pilot trial to determine the efficacy and safety of ibudilast, a potential glial attenuator, in chronic migraine. J Pain Res 9:899–907. https://doi.org/10.2147/JPR.S116968CrossRefPubMedPubMedCentral

22.

Landy SH, McGinnis JE, McDonald SA (2007) Clarification of developing and established clinical allodynia and pain-free outcomes. Headache 47(2):247–252. https://doi.org/10.1111/j.1526-4610.2006.00689.xCrossRefPubMed

23.

Raghavendra V, Tanga FY, DeLeo JA (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20(2):467–473. https://doi.org/10.1111/j.1460-9568.2004.03514.xCrossRefPubMed

24.

Linnerbauer M, Wheeler MA, Quintana FJ (2020) Astrocyte crosstalk in CNS inflammation. Neuron 108(4):608–622. https://doi.org/10.1016/j.neuron.2020.08.012CrossRefPubMedPubMedCentral

25.

Gong Q, Lin Y, Lu Z, Xiao Z (2020) Microglia-astrocyte cross talk through IL-18/IL-18R signaling modulates migraine-like behavior in experimental models of migraine. Neuroscience. 451:207–215. https://doi.org/10.1016/j.neuroscience.2020.10.019CrossRefPubMed

26.

Kim S, Son Y (2021) Astrocytes stimulate microglial proliferation and m2 polarization in vitro through crosstalk between astrocytes and microglia. Int J Mol Sci 22(16). https://doi.org/10.3390/ijms22168800

27.

Long T, He W, Pan Q, Zhang S, Zhang D, Qin G, Chen L, Zhou J (2020) Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model. J Headache Pain 21(1):1–17. https://doi.org/10.1186/s10194-019-1070-4CrossRef

28.

Zhang L, Kunkler PE, Knopp KL, Oxford GS, Hurley JH (2019) Role of intraganglionic transmission in the trigeminovascular pathway. Mol Pain 15:174480691983657. https://doi.org/10.1177/1744806919836570CrossRef

29.

Haanes KA, Edvinsson L (2019) Pathophysiological mechanisms in migraine and the identification of new therapeutic targets. CNS Drugs 33(6):525–537. https://doi.org/10.1007/s40263-019-00630-6CrossRefPubMed

30.

Melo-Carrillo A, Strassman AM, Nir RR, Schain AJ, Noseda R, Stratton J, Burstein R (2017) Fremanezumab—a humanized monoclonal anti-cgrp antibody—inhibits thinly myelinated (Aδ) but not unmyelinated (c) meningeal nociceptors. J Neurosci 37(44):10587–10596. https://doi.org/10.1523/JNEUROSCI.2211-17.2017CrossRefPubMedPubMedCentral

31.

Afroz S, Arakaki R, Iwasa T, Oshima M, Hosoki M, Inoue M, Baba O, Okayama Y, Matsuka Y (2019) CGRP induces differential regulation of cytokines from satellite glial cells in trigeminal ganglia and orofacial nociception. Int J Mol Sci 20(3). https://doi.org/10.3390/ijms20030711

32.

Martami F, Razeghi Jahromi S, Togha M, Ghorbani Z, Seifishahpar M, Saidpour A (2018) The serum level of inflammatory markers in chronic and episodic migraine: a case-control study. Neurol Sci 39(10):1741–1749. https://doi.org/10.1007/s10072-018-3493-0CrossRefPubMed

33.

Popiolek-Barczyk K, Ciechanowska A, Ciapała K, Pawlik K, Oggioni M, Mercurio D, de Simoni MG, Mika J (2020) The CCL2/CCL7/CCL12/CCR2 pathway is substantially and persistently upregulated in mice after traumatic brain injury, and CCL2 modulates the complement system in microglia. Mol Cell Probes 54:101671. https://doi.org/10.1016/j.mcp.2020.101671CrossRefPubMed

34.

Jaerve A, Müller HW (2012) Chemokines in CNS injury and repair. Cell Tissue Res 349(1):229–248. https://doi.org/10.1007/s00441-012-1427-3CrossRefPubMed

35.

Xue J, Zhang Y, Zhang J, Zhu Z, Lv Q, Su J (2021) Astrocyte-derived CCL7 promotes microglia-mediated inflammation following traumatic brain injury. Int Immunopharmacol 99:107975. https://doi.org/10.1016/j.intimp.2021.107975CrossRefPubMed

36.

Ouyang W, O’Garra A (2019) IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50(4):871–891. https://doi.org/10.1016/j.immuni.2019.03.020CrossRefPubMed

Title: Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup
Authors: Leyi Zhang
Chenglong Lu
Li Kang
Yingji Li
Wenjing Tang
Dengfa Zhao
Shengyuan Yu
Ruozhuo Liu
Publication date: 01-12-2022
Publisher: Springer Milan
Keywords: Migraine
Cytokines
Published in: The Journal of Headache and Pain / Issue 1/2022
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-021-01382-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors

Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients

Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients

The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials

The applicability research of the diagnostic criteria for 6.7.2 angiography headache in the international classification of headache disorders-3rd edition

Long term evaluation of a multidisciplinary trigeminal neuralgia service